Many people with obesity or binge eating show addiction-like behavioral changes that can be modeled in rodents with intermittent, extended access to palatable food. New neurobiological understanding of and therapeutic targets for compulsive eating are needed. PPARs are lipid-sensing transcription factors encoded by 3 genes (PPAR?, PPAR?, PPAR?/?) that were identified for their roles in peripheral regulation of fuel homeostasis. PPAR? and PPAR? also have received intense attention for their anti-addiction-like actions. Yet, the role of brain PPAR? receptors in the control of compulsive eating, which has overlapping striatal substrates with alcohol and substance use disorders, is entirely unknown. Here, we test the overarching hypothesis that brain peroxisome proliferator-activated receptors-delta subtype (PPAR?) inhibit addiction-like, aspects of eating. With a novel blood-brain barrier-penetrant selective PPAR? agonist (KD3010) and cre/lox tools to manipulate PPAR? function now available, the proposed studies address these gaps in the field and may yield new translational approaches and insight into the biology of brain PPAR? and their role in the control of compulsive eating and potentially other addiction phenotypes. Using an innovative, drug abuse-like mouse model, based on intermittent, extended access to highly palatable food, Aim 1 tests the roles of central vs. peripheral PPAR? receptors in compulsive-like food intake. Guided by preliminary data, Aim 2 test the functional role of PPAR? receptors in dopamine Drd2/Adora2a- vs Drd1- expressing medium spiny neurons. The resulting data and novel genetic and translationally-relevant pharmacological tools for this understudied PPAR? isotype will lay the groundwork for cell type- and anatomically-specific mechanistic studies and may lead to interventions for people affected by compulsive eating and potentially other forms of addiction.
This multidisciplinary project combines a non-brain penetrant (GW501516) and novel blood-brain barrier- penetrant selective PPAR? agonist (KD3010) as well as conditional cre/lox tools to manipulate PPAR? function to test the roles of brain vs. peripheral PPAR? receptors in addiction-like, compulsive eating. Based on data that implicate a role for striatal systems in compulsive eating and PPAR? biology, transgenic approaches will also test the role of brain PPAR? receptors in D1- vs D2-expressing striatal medium spiny neurons. Collectively, the resulting data and novel pharmacological and genetic tools for this understudied PPAR? isotype will lay the groundwork for cell type- and anatomically-specific mechanistic studies and may translate to interventions for people affected by compulsive eating and potentially other forms of addiction.
